Recursion Pharmaceuticals Inc (RXRX)
6.175
-0.74
(-10.64%)
USD |
NASDAQ |
Nov 15, 16:00
6.30
+0.12
(+2.02%)
After-Hours: 20:00
Recursion Pharmaceuticals Shares Outstanding: 286.64M for Oct. 31, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
October 31, 2024 | 286.64M |
October 07, 2024 | 286.15M |
September 30, 2024 | 285.93M |
August 06, 2024 | 282.24M |
July 31, 2024 | 281.11M |
June 30, 2024 | 280.88M |
June 28, 2024 | 268.43M |
April 30, 2024 | 237.66M |
April 12, 2024 | 237.52M |
March 31, 2024 | 237.51M |
January 31, 2024 | 234.65M |
December 31, 2023 | 233.81M |
October 31, 2023 | 215.87M |
September 30, 2023 | 215.56M |
July 31, 2023 | 211.68M |
June 30, 2023 | 202.73M |
April 30, 2023 | 192.36M |
April 17, 2023 | 192.31M |
March 31, 2023 | 192.23M |
January 31, 2023 | 191.23M |
Date | Value |
---|---|
December 31, 2022 | 191.02M |
October 31, 2022 | 189.56M |
October 27, 2022 | 188.37M |
September 30, 2022 | 174.07M |
July 31, 2022 | 173.08M |
June 30, 2022 | 172.82M |
April 30, 2022 | 172.01M |
April 18, 2022 | 171.68M |
March 31, 2022 | 171.08M |
February 28, 2022 | 170.77M |
December 31, 2021 | 170.27M |
October 31, 2021 | 168.99M |
September 30, 2021 | 168.64M |
July 31, 2021 | 168.48M |
June 30, 2021 | 168.43M |
April 30, 2021 | 168.32M |
April 20, 2021 | 165.79M |
April 16, 2021 | 162.16M |
April 15, 2021 | 159.91M |
April 12, 2021 | 155.91M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
155.91M
Minimum
Apr 12 2021
286.64M
Maximum
Oct 31 2024
204.95M
Average
191.13M
Median
Shares Outstanding Benchmarks
Revance Therapeutics Inc | 104.90M |
NovaBay Pharmaceuticals Inc | 4.886M |
Palatin Technologies Inc | 19.55M |
iBio Inc | 8.638M |
Theriva Biologics Inc | 1.005M |